HIV and mitochondria: More than just drug toxicity

Journal of Infectious Diseases

Volumn 205, Issue 12, 2012, Pages 1769-1771

  Hulgan, Todd ^a   Gerschenson, Mariana ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME C; MITOCHONDRIAL DNA; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TOLL LIKE RECEPTOR 9;

ADIPOSE TISSUE; APOPTOSIS; CARDIOVASCULAR DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; ENZYME RELEASE; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LACTIC ACIDOSIS; LIPOATROPHY; LYMPHOCYTE ACTIVATION; METABOLIC SYNDROME X; MICROARRAY ANALYSIS; MYOPATHY; NOTE; OXIDATIVE PHOSPHORYLATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROTEIN BINDING;

ADIPOSE TISSUE; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DNA, MITOCHONDRIAL; FEMALE; HIV INFECTIONS; HUMANS; MALE; MITOCHONDRIA;

EID: 84861563042     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis105     Document Type: Note

References (31)

1. Sterne JA, May M, Costagliola D, et al. Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet 2009; 373:1352-63.
2. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
3. Feeney ER, Mallon PW. Impact of mitochondrial toxicity of HIV-1 antiretroviral drugs on lipodystrophy and metabolic dysregulation. Curr Pharm Des 2010; 16:3339-51.
4. Grinspoon S, Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 2005; 352:48-62.
5. Rodriguez-Novoa S, Alvarez E, Labarga P, Soriano V. Renal toxicity associated with tenofovir use. Expert Opin Drug Saf 2010; 9:545-59.
6. McComsey GA, Tebas P, Shane E, et al. Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis 2010; 51:937-46.
7. Heaton RK, Clifford DB, Franklin DR Jr, et al. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology 2010; 75:2087-96.
8. Martin J, Volberding P. HIV and premature aging: a field still in its infancy. Ann Intern Med 2010; 153:477-9.
9. Payne BA, Wilson IJ, Hateley CA, et al. Mitochondrial aging is accelerated by antiretroviral therapy through the clonal expansion of mtDNA mutations. Nat Genet 2011; 43:806-10.
10. Herlitz LC, Mohan S, Stokes MB, Radhakrishnan J, D'Agati VD, Markowitz GS. Tenofovir nephrotoxicity: acute tubular necrosis with distinctive clinical, pathological, and mitochondrial abnormalities. Kidney Int 2010; 78:1171-7.
11. Guo Y, Yang TL, Liu YZ, et al. Mitochondriawide association study of common variants in osteoporosis. Ann Hum Genet 2011; 75:569-74.
12. Pan G, Yang Z, Ballinger SW, McDonald JM. Pathogenesis of osteopenia/osteoporosis induced by highly active anti-retroviral therapy for AIDS. Ann N Y Acad Sci 2006; 1068:297-308.
13. Grammas P, Martinez J, Miller B. Cerebral microvascular endothelium and the pathogenesis of neurodegenerative diseases. Expert Rev Mol Med 2011; 13:e19.
14. Wallace DC. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005; 39: 359-407.
15. Roumier T, Castedo M, Perfettini JL, et al. Mitochondrion-dependent caspase activation by the HIV-1 envelope. Biochem Pharmacol 2003; 66:1321-9.
16. Muthumani K, Choo AY, Hwang DS, et al. Mechanism of HIV-1 viral protein Rinduced apoptosis. Biochem Biophys Res Commun 2003; 304:583-92.
17. Arnoult D, Petit F, Lelievre JD, Estaquier J. Mitochondria in HIV-1-induced apoptosis. Biochem Biophys Res Commun 2003; 304:561-74.
18. Garrabou G, Lopez S, Moren C, et al. Mitochondrial damage in adipose tissue of untreated HIV-infected patients. AIDS 2011; 25:165-70.
19. Morse C, et al. HIV Infection and Antiretroviral therapy have divergent effects on mitochondria in adipose tissue. J Infect Dis 2012; 205:1778-87.
20. Casula M, Vrisekoop N, Wit FW, et al. Mitochondrial DNA decline in T cells of HIV-1 seroconverters may be dependent on immune activation. J Infect Dis 2007; 196:371-6.
21. Maagaard A, Holberg-Petersen M, Lovgarden G, Holm M, Pettersen FO, Kvale D. Distinct mechanisms for mitochondrial DNA loss in T and B lymphocytes from HIV-infected patients exposed to nucleoside reverse-transcriptase inhibitors and those naive to antiretroviral treatment. J Infect Dis 2008; 198:1474-81.
22. Zhang Q, Raoof M, Chen Y, et al. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 2010; 464:104-7.
23. Cossarizza A, Pinti M, Nasi M, et al. Increased plasma levels of extracellular mitochondrial DNA during HIV infection: a new role for mitochondrial damageassociated molecular patterns during inflammation. Mitochondrion 2011; 11: 750-5.
24. Maagaard A, Holberg-PetersenM, Kollberg G, Oldfors A, Sandvik L, Bruun JN. Mitochondrial (mt)DNA changes in tissue may not be reflected by depletion of mtDNA in peripheral blood mononuclear cells in HIV-infected patients. Antivir Ther 2006; 11:601-8.
25. Yerroum M, Pham-Dang C, Authier FJ, Monnet I, Gherardi R, Chariot P. Cytochrome c oxidase deficiency in the muscle of patients with zidovudine myopathy is segmental and affects both mitochondrial DNA-and nuclear DNA-encoded subunits. Acta Neuropathol 2000; 100:82-6.
26. Cote HC, Brumme ZL, Craib KJ, et al. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med 2002; 346:811-20.
27. Casula M, van der Valk M, Wit FW, Nievaard MA, Reiss P. Mitochondrial DNA assessment in adipocytes and peripheral blood mononuclear cells of HIV-infected patients with lipodystrophy according to a validated case definition. HIV Med 2007; 8:32-7.
28. Petit C, Mathez D, Barthelemy C, et al. Quantitation of blood lymphocyte mitochondrial DNA for the monitoring of antiretroviral drug-induced mitochondrial DNA depletion. J Acquir Immune Defic Syndr 2003; 33:461-9.
29. Shikuma CM, Gerschenson M, Chow D, et al. Mitochondrial oxidative phosphorylation protein levels in peripheral blood mononuclear cells correlate with levels in subcutaneous adipose tissue within samples differing by HIV and lipoatrophy status. AIDS Res Hum Retroviruses 2008; 24:1255-62.
30. Cote HC, Gerschenson M, Walker UA, et al. Quality assessment of human mitochondrial DNA quantification: MITONAUTS, an international multicentre survey. Mitochondrion 2011; 11:520-7.
31. Gerschenson M, Shiramizu B, LiButti DE, Shikuma CM. Mitochondrial DNA levels of peripheral blood mononuclear cells and subcutaneous adipose tissue from thigh, fat and abdomen of HIV-1 seropositive and negative individuals. Antivir Ther 2005; 10(Suppl 2):M83-9.